Telaprevir (VX-950)
Catalog #
27051
$560
*
●
●
Purchase
Description
Telaprevir inhibits the hepatitis C virus NS3-4A serine protease, leading to the block of viral polyprotein processing. This eventually leads to a decrease of viral RNA replication, HCV RNA levels, as well as and protein levels in the Con1 (genotype 1b) subgenomic HCV replicon cells. This occurs in a time- and dose-dependent manner.
●
Synonyms
VX-950
●
Product Data Gallery
Product Info
Storage and Usage
Citations
Purity
≥98%
Format
Off-white powder
Formula
C36H53N7O6
MW
679.8 Da
Solubility
≥100 mg/ml in DMSO <1 mg/ml in Water <1 mg/ml in Ethanol
Biological Activity
Telaprevir shows a significant time-dependent increase in inhibitory effect on the replication of HCV RNA with IC50 values of 574 nM, 488 nM, 210 nM and 139 nM for 24, 48, 72 and 120 hours incubation, respectively. On average it displays an IC50 of 354 nM and an average IC90 of 830 nM, respectively, from three independent experiments using 48 hours incubation.
CAS Registry #
402957-28-2
Powered by Bioz
6405 Mira Mesa Blvd. Suite 100
San Diego, CA 92121
858-202-1401
San Diego, CA 92121
858-202-1401
Products are for Research Use Only
COMPANY
Copyright © 2024
BPS Bioscience, Inc.
All rights reserved.
Diagrams on this website are created with BioRender.com.